About this Research Topic
Schistosomiasis is a parasitic disease highly prevalent among the most impoverished populations. Trematode worms of the genus Schistosoma cause this neglected tropical disease that affects over 207 million people worldwide. In 2012, several countries affected by schistosomiasis signed the WHA65.21 resolution of the World Health Assembly (WHA), which established as goals (i) the control of disease morbidity by 2020 and (ii) the elimination of the disease as a public health problem by 2025. However, to achieve these goals, it is necessary to better understand the disease and its dynamics, the parasite's immunobiology and its relationship with the definitive and intermediate hosts. This will allow to develop vaccines, more effective drugs, precise diagnostic methods and better strategies to control the transmission of schistosomiasis.
For the past 33 years, the Oswaldo Cruz Foundation (Fiocruz, Brazilian Ministry of Health) has organized the International Symposium on Schistosomiasis on a biennial basis. Historically, this symposium brings together approximately 350 people, accounting for world-renowned scientists, public health managers, students, and policy makers, to translate the knowledge generated in research and technology institutions into actions and products to improve the quality of life from the population affected by schistosomiasis.
Since, due to COVID-19 pandemic declared by the WHO, the 16th edition of the International Symposium on Schistosomiasis has been postponed to 2021, this Pre-Conference Research Topic is designed to provide all the researchers from the Schistosomiasis community the opportunity to share their latest research. Researchers that intend to attend the Symposium are particularly welcome to submit their contributions.
In this Research Topic, we aim to gather a collection of state-of-the-art articles covering all aspects of schistosomiasis, in particular, but not limited, to the following subtopics:
• Host-Parasite Interactions
• Biology of schistosome and its hosts (Immunology, genetics, biochemistry, systematics, bioinformatics, genomics and Molecular Biology)
• Strategies for schistosomiasis control and elimination
• Vaccine
• Drugs
• Diagnosis
• Epidemiology
• Health Education and promotion
Submission of basic and translational Original Research, Review, Mini-Review, Methods and Perspectives articles are welcome.
For the past 33 years, the Oswaldo Cruz Foundation (Fiocruz, Brazilian Ministry of Health) has organized the International Symposium on Schistosomiasis on a biennial basis. Historically, this symposium brings together approximately 350 people, accounting for world-renowned scientists, public health managers, students, and policy makers, to translate the knowledge generated in research and technology institutions into actions and products to improve the quality of life from the population affected by schistosomiasis.
Since, due to COVID-19 pandemic declared by the WHO, the 16th edition of the International Symposium on Schistosomiasis has been postponed to 2021, this Pre-Conference Research Topic is designed to provide all the researchers from the Schistosomiasis community the opportunity to share their latest research. Researchers that intend to attend the Symposium are particularly welcome to submit their contributions.
In this Research Topic, we aim to gather a collection of state-of-the-art articles covering all aspects of schistosomiasis, in particular, but not limited, to the following subtopics:
• Host-Parasite Interactions
• Biology of schistosome and its hosts (Immunology, genetics, biochemistry, systematics, bioinformatics, genomics and Molecular Biology)
• Strategies for schistosomiasis control and elimination
• Vaccine
• Drugs
• Diagnosis
• Epidemiology
• Health Education and promotion
Submission of basic and translational Original Research, Review, Mini-Review, Methods and Perspectives articles are welcome.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
